Hanzepoort B.V.
Overview
Hanzepoort B.V. is an investment firm and a member of the Triade Group, closely linked to the University Medical Center Groningen, focusing on investments in innovative start-ups in the field of Healthy Aging.
Portfolio Companies
3
Website
triadegroep.nlInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vitalnext Products BV | Oct 2020 | Series B | Co-investor |
| VRelax | Apr 2020 | Seed | Co-investor |
| ViciniVax BV | - | Seed | Co-investor |
Key People
Paavo de Leng
Junior Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hanzepoort B.V. based?
Hanzepoort B.V. is headquartered in Groningen, Netherlands.
When was Hanzepoort B.V. founded?
Founding year information for Hanzepoort B.V. is not publicly available.
How many portfolio companies does Hanzepoort B.V. have?
Hanzepoort B.V. has 3 portfolio companies in Caplight's dataset.
What are some companies in Hanzepoort B.V.'s portfolio?
Recent investments visible on Caplight include Vitalnext Products BV, VRelax, Vitalnext Products BV, ViciniVax BV.
What was Hanzepoort B.V.'s most recent investment?
Hanzepoort B.V.'s most recent investment on Caplight was in Vitalnext Products BV in 2020.
What sectors does Hanzepoort B.V. focus on?
Hanzepoort B.V. focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does Hanzepoort B.V. focus on?
Hanzepoort B.V. typically invests at the Early stage.